Annual report
286A.TEDINET S100VGY6
Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 117
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥18.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥16.6bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.9bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥784m | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥980m | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥60.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥51.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥42.6bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥39.2bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.8bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-12-31d | Cons. | Net assets |
| Cash and deposits | ¥11.2bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥209m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥406m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.4bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3.5bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.0bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥64.4 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.18 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.8 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥63.12 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥507.67 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥362.04 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥324.44 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 29.9% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.7% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.1% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 833 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 769 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 699 | at 2022-12-31d | Cons. | Number of employees |
| Revenue | ¥5.6bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥5.4bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥4.0bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.4bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥356m | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥827m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥771m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.8bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥709m | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥1.3bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥565m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥583m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥36.0bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥29.2bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥22.3bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.5bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥24.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥19.2bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥19.2bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.9bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥10.0bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥9.3bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.3bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥58.56 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.72 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.24 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.91 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.53 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥57.4 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥477.26 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥333.28 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.1 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥265.41 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥245.51 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.7% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 37,982,900 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 167 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 130 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 117 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 119 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 87 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-01-01 → 2024-12-31 | ¥380,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-12-31 | 11 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-12-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-12-31 | −¥140m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥70m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥1.2bn |
| Comprehensive Medical Management Support Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥309m |
| Comprehensive Medical Management Support Businessreportable segment | employees | at 2024-12-31 | 137 pure |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.8bn |
| Elderly Care Related Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥514m |
| Elderly Care Related Businessreportable segment | employees | at 2024-12-31 | 594 pure |
| Elderly Care Related Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.9bn |
| Elderly Care Related Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.9bn |
| Elderly Care Related Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥309m |
| Specially Controlled Medical Device Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥33m |
| Specially Controlled Medical Device Businessreportable segment | employees | at 2024-12-31 | 57 pure |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.5bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.5bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥485m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥857m |
| —segment total | employees | at 2024-12-31 | 788 pure |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥3.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-01-01 → 2024-12-31 | ¥857m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-12-31 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-01-01 → 2023-12-31 | ¥551,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥36m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-12-31 | ¥36m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥215m |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥55m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥898m |
| Comprehensive Medical Management Support Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥305m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥5.4bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥5.4bn |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.0bn |
| Elderly Care Related Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥468m |
| Elderly Care Related Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥6.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥6.7bn |
| Elderly Care Related Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥626m |
| Specially Controlled Medical Device Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥10m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥6.0bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥6.0bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥377m |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥783m |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥18.0bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥18.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-01-01 → 2023-12-31 | ¥784m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-12-31 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-12-31 | 11 pure |
| Comprehensive Medical Management Support Businessreportable segment | employees | at 2024-12-31 | 118 pure |
| Elderly Care Related Businessreportable segment | employees | at 2024-12-31 | 4 pure |
| —segment total | employees | at 2024-12-31 | 122 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,646
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_DeferredGainsOrLossesOnHedgesMember | 109645000 | JPY |
| Net assets | CurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember | -13848000 | JPY |
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | 93136000 | JPY |
| Net assets | CurrentYearInstant_NonControllingInterestsMember | 991270000 | JPY |
| Net assets | CurrentYearInstant | 18951212000 | JPY |
| Income before income taxes | Prior1YearDuration | 1749814000 | JPY |
| Income before income taxes | CurrentYearDuration | 3114512000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 839496000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 926617000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 44313000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | － | JPY |
| Amortization of goodwill ope cf | Prior1YearDuration | 95193000 | JPY |
| Amortization of goodwill ope cf | CurrentYearDuration | 124096000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -86110000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | -497712000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | 27956000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | 137315000 | JPY |
| Increase decrease in provision for product warranties ope cf | Prior1YearDuration | 112650000 | JPY |
| Increase decrease in provision for product warranties ope cf | CurrentYearDuration | -85279000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -31413000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -22278000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 474830000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 507803000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YearDuration | -18519000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYearDuration | -25116000 | JPY |
| Loss gain on valuation of derivatives ope cf | Prior1YearDuration | -74025000 | JPY |
| Loss gain on valuation of derivatives ope cf | CurrentYearDuration | -2815000 | JPY |
| Listing expenses ope cf | Prior1YearDuration | － | JPY |
| Listing expenses ope cf | CurrentYearDuration | 40494000 | JPY |
| Commission income ope cf | Prior1YearDuration | － | JPY |
| Commission income ope cf | CurrentYearDuration | -108000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | -7247000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -1632000 | JPY |
| Loss gain on investments in partnership ope cf | Prior1YearDuration | 15275000 | JPY |
| Loss gain on investments in partnership ope cf | CurrentYearDuration | -6161000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YearDuration | -59999000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYearDuration | -55557000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YearDuration | -369000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYearDuration | -289961000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -129524000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | -236347000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -444605000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | 204181000 | JPY |
| Decrease increase in operating loans receivable ope cf | Prior1YearDuration | -122500000 | JPY |
| Decrease increase in operating loans receivable ope cf | CurrentYearDuration | -2200760000 | JPY |
| Decrease increase in lease investment assets ope cf | Prior1YearDuration | -1825530000 | JPY |
| Decrease increase in lease investment assets ope cf | CurrentYearDuration | -221942000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 220481000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 497795000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YearDuration | -346156000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |